Autoantibody screening in Guillain–Barré syndrome

Autoantibody screening in Guillain–Barré syndrome

Abstract Background Guillain–Barré syndrome (GBS) is an acute inflammatory neuropathy with a heterogeneous presentation. Although some evidences support the role of autoantibodies in its pathogenesis, the target antigens remain unknown in a substantial proportion of GBS patients. The objective of th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cinta Lleixà, Lorena Martín-Aguilar, Elba Pascual-Goñi, Teresa Franco, Marta Caballero, Noemí de Luna, Eduard Gallardo, Xavier Suárez-Calvet, Laura Martínez-Martínez, Jordi Diaz-Manera, Ricard Rojas-García, Elena Cortés-Vicente, Joana Turón, Carlos Casasnovas, Christian Homedes, Gerardo Gutiérrez-Gutiérrez, María Concepción Jimeno-Montero, José Berciano, Maria José Sedano-Tous, Tania García-Sobrino, Julio Pardo-Fernández, Celedonio Márquez-Infante, Iñigo Rojas-Marcos, Ivonne Jericó-Pascual, Eugenia Martínez-Hernández, Germán Morís de la Tassa, Cristina Domínguez-González, Cándido Juárez, Isabel Illa, Luis Querol
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Guillain–Barré syndrome (GBS)
Autoantibodies
Anti-ganglioside
Neurons
Prognosis
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/4683d496544444ce8ced3a1c5a156d32
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/4683d496544444ce8ced3a1c5a156d32

Ejemplares similares